Note: Ingredients listed on restricted chemical lists
EC/CAS
97-63-2
Name of the chemical
methacrylic acid, ethyl ester
Concentration
N/A
EC/CAS
97-90-5
Name of the chemical
methacrylic acid, diester with ethyleneglycol
Concentration
N/A
EC/CAS
868-77-9
Name of the chemical
2-hydroxyethyl methacrylate
Concentration
N/A
EC/CAS
99-97-8
Name of the chemical
N,N-dimethyl-p-toluidine
Concentration
N/A
General Information
Revision date
2016-04-02
Product name
Illume Fusion Monomer
Substance name
Blend of ingredients; principally ethyl methacrylate
1.2.1 Relevant identified uses
Nail liquid preparation. Monomer which may undergo polymerisation processes
Icons in SDS
Company Information
company name
Hawley International Pty Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
alan@hawley.net.au
Section 2
Hazard statements
This product is classified as: Xi, Irritating. F, Flammable. Hazardous according to the criteria of ASCC. Dangerous according to the Australian Dangerous Goods (ADG) Code. R10, R43, R36/37/38. Flammable. May cause sensitisation by skin contact. Irritating to eyes, respiratory system and skin.
Precautionary statements
S2, S9, S16, S23, S29, S33, S24/25, S37/39. Keep out of reach of children. Keep container in a well ventilated place. Keep away from sources of ignition - No smoking. Do not empty into drains. Take precautionary measures against static discharges. Avoid contact with skin and eyes. Wear suitable gloves and eye/face protection.
SUSDP Classification
S5
ADG classification
Class 3 (FLAMMABLE LIQUID, N.O.S.)
UN Number
1993 Emergency Overview Physical Description & Colour: Clear, violet coloured liquid. Odour: Sharp ester-like odour.
Health hazards
irritating to eyes, respiratory system and skin, possible skin sensitiser
Potential health effects
Inhalation: Short Term Exposure: Available data indicates that this product is not harmful. However product is an inhalation irritant. Symptoms may include headache, irritation of nose and throat and increased secretion of mucous in the nose and throat. Other symptoms may also become evident, but they should disappear after exposure has ceased. Long Term Exposure: No data for health effects associated with long term inhalation. Skin Contact: Short Term Exposure: Classified as a potential sensitiser by skin contact. Exposure to a skin sensitiser, once sensitisation has occurred, may manifest itself as skin rash or inflammation, and in some individuals this reaction can be severe. In addition product is a skin irritant. Symptoms may include itchiness and reddening of contacted skin. Other symptoms may also become evident, but all should disappear once exposure has ceased. Long Term Exposure: No data for health effects associated with long term skin exposure. Eye Contact: Short Term Exposure: This product is an eye irritant. Symptoms may include stinging and reddening of eyes and watering which may become copious. Other symptoms may also become evident. If exposure is brief, symptoms should disappear once exposure has ceased. However, lengthy exposure or delayed treatment may cause permanent damage. Long Term Exposure: No data for health effects associated with long term eye exposure. Ingestion: Short Term Exposure: Significant oral exposure is considered to be unlikely. However, this product is an oral irritant. Symptoms may include burning sensation and reddening of skin in mouth and throat. Other symptoms may also become evident, but all should disappear once exposure has ceased. Long Term Exposure: No data for health effects associated with long term ingestion. Carcinogen Status: ASCC: No significant ingredient is classified as carcinogenic by ASCC. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: No significant ingredient is classified as carcinogenic by IARC.
